Phosphodiesterase Inhibitors - 10 Angebote vergleichen
Bester Preis: Fr. 143.87 (€ 147.12)¹ (vom 09.06.2016)1
Symbolbild
Phosphodiesterase Inhibitors (1996)
EN HC USISBN: 9780122107207 bzw. 0122107209, in Englisch, Academic Press, gebundenes Buch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, Versandkosten nach: USA.
Von Händler/Antiquariat, Mountainview Books.
New York: Academic Press, 1996. Book. Very Good Condition. Hardcover. 4to - over 9¾" - 12" tall. 228 pgs. Provides comprehensive description of available PDE inhibitors. Green boards; tan dust jacket shows a few small chips to top edge of dust jacket. Clean and tightly bound..
Von Händler/Antiquariat, Mountainview Books.
New York: Academic Press, 1996. Book. Very Good Condition. Hardcover. 4to - over 9¾" - 12" tall. 228 pgs. Provides comprehensive description of available PDE inhibitors. Green boards; tan dust jacket shows a few small chips to top edge of dust jacket. Clean and tightly bound..
2
Phosphodiesterase Inhibitors
EN NWISBN: 9780122107207 bzw. 0122107209, in Englisch, Academic Press, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd.
Life Sciences, Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Printbook.
Life Sciences, Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Printbook.
3
Phosphodiesterase Inhibitors (1958)
~EN USISBN: 9780122107207 bzw. 0122107209, vermutlich in Englisch, Academic Press, Vereinigte Staaten von Amerika, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, In Stock, plus shipping.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Key Features * Utilizes actual testing and research of new PDE inhibitors * Valuable for researchers and students alike.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Key Features * Utilizes actual testing and research of new PDE inhibitors * Valuable for researchers and students alike.
4
Phosphodiesterase Inhibitors
EN NW EBISBN: 9780122107207 bzw. 0122107209, in Englisch, Elsevier Science, neu, E-Book.
Lieferung aus: Vereinigte Staaten von Amerika, E-Book zum download.
Science, Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Key Features * Utilizes actual testing and research of new PDE inhibitors * Valuable for researchers and students alike, eBook.
Science, Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Key Features * Utilizes actual testing and research of new PDE inhibitors * Valuable for researchers and students alike, eBook.
5
Phosphodiesterase Inhibitors (1996)
EN NW EBISBN: 9780080538815 bzw. 0080538819, in Englisch, Academic Press, neu, E-Book.
Lieferung aus: Niederlande, Direct beschikbaar.
bol.com.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes th... Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. It utilizes actual testing and research of new PDE inhibitors. It is valuable for researchers and students alike. Productinformatie:Taal: Engels;Vertaald uit het: Engels;Formaat: ePub met kopieerbeveiliging (DRM) van Adobe;Bestandsgrootte: 21.60 MB;Kopieerrechten: Het kopiëren van (delen van) de pagina's is niet toegestaan ;Printrechten: Het printen van de pagina's is niet toegestaan;Voorleesfunctie: De voorleesfunctie is uitgeschakeld;Geschikt voor: Alle e-readers te koop bij bol.com (of compatible met Adobe DRM). Telefoons/tablets met Google Android (1.6 of hoger) voorzien van bol.com boekenbol app. PC en Mac met Adobe reader software;ISBN10: 0080538819;ISBN13: 9780080538815; Engels | Ebook | 1996.
bol.com.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes th... Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. It utilizes actual testing and research of new PDE inhibitors. It is valuable for researchers and students alike. Productinformatie:Taal: Engels;Vertaald uit het: Engels;Formaat: ePub met kopieerbeveiliging (DRM) van Adobe;Bestandsgrootte: 21.60 MB;Kopieerrechten: Het kopiëren van (delen van) de pagina's is niet toegestaan ;Printrechten: Het printen van de pagina's is niet toegestaan;Voorleesfunctie: De voorleesfunctie is uitgeschakeld;Geschikt voor: Alle e-readers te koop bij bol.com (of compatible met Adobe DRM). Telefoons/tablets met Google Android (1.6 of hoger) voorzien van bol.com boekenbol app. PC en Mac met Adobe reader software;ISBN10: 0080538819;ISBN13: 9780080538815; Engels | Ebook | 1996.
6
Phosphodiesterase Inhibitors (Handbook of Immunopharmacology) (1996)
EN HC NW FEISBN: 9780122107207 bzw. 0122107209, in Englisch, 228 Seiten, Academic Press, gebundenes Buch, neu, Erstausgabe.
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days.
Von Händler/Antiquariat, _nearfine_.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Key Features * Utilizes actual testing and research of new PDE inhibitors * Valuable for researchers and students alike, Hardcover, Ausgabe: 1, Label: Academic Press, Academic Press, Produktgruppe: Book, Publiziert: 1996-09-10, Studio: Academic Press, Verkaufsrang: 2122073.
Von Händler/Antiquariat, _nearfine_.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting. Key Features * Utilizes actual testing and research of new PDE inhibitors * Valuable for researchers and students alike, Hardcover, Ausgabe: 1, Label: Academic Press, Academic Press, Produktgruppe: Book, Publiziert: 1996-09-10, Studio: Academic Press, Verkaufsrang: 2122073.
7
Phosphodiesterase Inhibitors (1996)
EN HC NWISBN: 9780122107207 bzw. 0122107209, in Englisch, Elsevier Science Publishing Co Inc, gebundenes Buch, neu.
Lieferung aus: Niederlande, 12 werkdagen.
bol.com.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been in use since 1958. A variety of these inhibitors are under test as potential anti-inflammatory drugs. This book summarizes the developments, as well as giving a comprehensive description of the compounds available.Taal: Engels;Vertaald uit het: Engels;Afmetingen: 18x248x191 mm;Gewicht: 685,00 gram;Verschijningsdatum: augustus 1996;ISBN10: 0122107209;ISBN13: 9780122107207; Engelstalig | Hardcover | 1996.
bol.com.
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been in use since 1958. A variety of these inhibitors are under test as potential anti-inflammatory drugs. This book summarizes the developments, as well as giving a comprehensive description of the compounds available.Taal: Engels;Vertaald uit het: Engels;Afmetingen: 18x248x191 mm;Gewicht: 685,00 gram;Verschijningsdatum: augustus 1996;ISBN10: 0122107209;ISBN13: 9780122107207; Engelstalig | Hardcover | 1996.
8
Articles on Phosphodiesterase Inhibitors, Including: Sildenafil, Tadalafil, Vardenafil, Pde5 Inhibitor, Cgmp-Specific Phosphodiesterase Type 5, Udenafil, Avanafil, Acetildenafil, Icariin, Thiomethisosildenafil, Lodenafil, Mirodenafil (2011)
EN PB NWISBN: 9781244172838 bzw. 1244172839, in Englisch, Hephaestus Books, Charleston SC, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, plus shipping, Shipping area: DOM.
Von Händler/Antiquariat, Through The Stacks LLC, NY, Brockport, [RE:3].
Ships worldwide with delivery confirmation. Trade paperback.
Von Händler/Antiquariat, Through The Stacks LLC, NY, Brockport, [RE:3].
Ships worldwide with delivery confirmation. Trade paperback.
9
Articles on Phosphodiesterase Inhibitors, Including: Caffeine, Phosphodiesterase Inhibitor, Theobromine, Theophylline, Dipyridamole, Papaverine, Aminophylline, Anagrelide, Paraxanthine, Tofisopam, Vinpocetine, Ehna, Ibmx (2011)
EN PB NWISBN: 9781243256393 bzw. 1243256397, in Englisch, Hephaestus Books, Charleston SC, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, plus shipping, Shipping area: DOM.
Von Händler/Antiquariat, Through The Stacks LLC, NY, Brockport, [RE:3].
Ships worldwide with delivery confirmation. Trade paperback.
Von Händler/Antiquariat, Through The Stacks LLC, NY, Brockport, [RE:3].
Ships worldwide with delivery confirmation. Trade paperback.
Lade…